ArticleAdvanced healthcare materials2023

Repurposing FDA-Approved Drugs for Temozolomide-Resistant IDH1 Mutant Glioma Using High-Throughput Miniaturized Screening on Droplet Microarray Chip.

Haijun Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.